Price (delayed)
$1.36
Market cap
$20.82M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.39
Enterprise value
$13.16M
Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four programs:
There are no recent dividends present for ACER.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.